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Venom of the Australian tiger snake, Notechis scutatm xutatus was fractionated by conventional ion-exchange chromatography. The fraction con- 
taining notexin, a well-known single-chain toxic phospholipase AZ, was further purified by reverse-phase high-performance liquid chromatography. 
Two main components were isolated and the major one corresponded to notexin. The other component, designated as note&is N,, was an isoform 
of notexin. Note&is N, and notexin possessed similar in vitro esterase activity, in vitro neuromuscular activity and in vivo lethality. Amino acid 
composition and sequence of the S#~~~~~QCOC~ amus VS-protease peptides demonstrated that primary structures of notechis N, and notexin 
differed from each other by a single substitution amongst 119 amino acids: Lys+Arg at position 16. 
Notexin; Isoform; Phospholipase 4; Reverse-phase high-performance hquid chromatog~phy 
1. INTRODUCTION 
Notexin, from venom of the Australian tiger snake, 
Note&is seutatus cutatus, is one of the most toxic 
single-chain phospholipase AZS (EC 3.1.1.4) which has 
both presynapti~ and myotoxic activities [1,2]. N. s. 
scutaf~s venom was previously reported to contain 
notechis II-5 [3] and notechis II-l [4] which differ in se- 
quence from notexin by 8 and 40 amino acids, respec- 
tively, and possess different toxic and enzymatic poten- 
cies. The primary structure of notexin was determined 
some years ago [5], using a protein which was purified 
by low-pressure gel filtration followed by cation- 
exchange chromatography [6], Notexin has been exten- 
sively used in a variety of neurophysiological studies 
(for reviews, see [7-91). 
For use in studies involving chemical modifications, 
the protein of interest must be as pure as possible. In the 
course of a set of experiments devoted to the determina- 
tion of the functional site of notexin [lo], we recon- 
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sidered the initial purification procedure and observed 
that the ion-exchange fraction containing notexin [6] 
was in fact composed of several components which 
were separated from each other by RP-HPLC. This 
paper reports on the biochemical characterization of 
the two main ones. 
2. MATERIALS AND METHODS 
IV. s. scutatus venom was collected in the Victoria region of 
Australia and purchased from the Australian Reptile Park (Gosford, 
Australia). It was chromatographed on a Biorex-70 column (Biorad, 
FRO), according to Karlsson et al. [6]. The fraction containing notex- 
in was dialyzed three times against 0.05 M ammonium acetate and 
lyophilized. It was rechromatographed by RP-HPLC on a Nucleosil 
butyl large pore column 4.6 x 250 mm (SFCC, Neuilly-Plaisance, 
France) with a Waters 510 gradient system (Milford, MA, USA), us- 
ing an acetonitrile linear gradient in 0.1% trifluoroacetic acid: 
23.8-X&0% CHsCN for 75 min at 1 mllmin. 
Amino acid analysis of proteins and peptides was determined ac- 
cording to [ll] using an LKB 4400 amino acid analyzer (LKB, 
Sweden). 
Reduction, S-carboxymethylation, and enzymatic treatment of 
proteins were performed as previously described [lo]. The reduced 
and blocked peptide samples were sequenced with a model 470A or 
47714 protein sequencer, and the resulting phenylthiohydantoin 
residues from each cycle were analyzed by HPLC using the on-line 
model 120 A phenylthiodantoin analyzer (Applied Biosystems, CA, 
USA). 
The LDSOS were determined using the sequential method of Dixon 
and Mood 1121. The protein was injected into the vein of the tail of 
female BALB/c mice (b.wt. 20 f 2 g). injected mice were examined 
24 h, 48 h, and one week after injection. 
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Fig. 1. Elution profile of notexin by RP-HPLC on a butyl large pore 
column. Elution was performed with a linear gradient of CHsCN in 
0.1% trifluoroacetic acid at a flow rate of 1.0 ml/min. The iniected 
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Fig.2. (A) In vitro effects of notexin (0) and note&is N, (A) at 147 
nM on indirectiy elicited twitches of chick biventer cervicis prepara- 
tions stimulated at 0.1 Hz. Points are mean f SEM (n = 6). (B) Ef- 
fects of notexin (0) and notechis N, (A) at 73 nM on endplate poten- 
tial (E.p.p.) amphtude in frog cutaneous pectoris preparations. 
Values have been normalized to a control E.p.p, amplitude of 1. Ex- 
perimental values were 1.9 mV (0) and 0.95 mV (A). 
sample was the fraction containing notexin (400 ue) obtained after 
chromatography on a Biorex-70 column of N. s. scutatus crude 
venom. The venom was collected in the Victoria region of Australia, 
periments were also performed with intracellular ecording methods 
on frog (Rana hiens) cutaneous uectoris vrevarations. as described 
The effect of proteins (147 nM) on neuromuscular t ansmission was 
assessed in vitro by using the chick biventer cervicis nerve-muscle 
preparation, as described dsewhere [lo]. Responses were obtained to 
indirect stimulation of the nerve at 0.1 Hz and the time-course of 
twitch bfockade in the presence of proteins was monitored. Ex- 
_. __ . _ _ 
elsewhere [13]. Muscles were prevented from contracting by reducing 
the release of acetylcholine by changing the Ca2* : Mg”’ ratio. EPPS 
and MEPPS were recorded before and after the application of toxins. 
The effects of the toxins on nerve terminal action potentials were also 
determined, using the mouse triangularis sterni preparation 1131. 
Enzymatic assays were performed using a titrimetric method [14]. 
Titration of fatty acids released from egg yolk phosphatidylcholine 
Table 1 
Amino acid composition of notechis N, and notechis N, 
Amino acid Notexin Notechis N, Notechis N, 
Aspartic acid 18 17.7 (18) 17.4 (18) 
Threonine 3 2.99 ( 3) 3.06 ( 3) 
Serine 3 3.13 ( 3) 3.11 ( 3) 
Glutamic acid 7 6.97 ( 7) 6.96 ( 7) 
Proline 5 5.20 ( 5) 5.15 ( 5) 
Glycine 10 9.99 (10) 10.50 (10) 
Alanine 9 9.04 ( 9) 8.50 ( 9) 
Half-cystine 14 ND ND 
Valine 4 4.11 ( 4) 4.07 ( 4) 
Methionine 2 2.07 ( 2) 1.97 ( 2) 
Isoleucine 4 3.67 ( 4) 3.70 ( 4) 
Leucine 4 4.20 ( 4) 4.06 ( 4) 
Tyrosine 10 9.55 (10) 9.50 (10) 
Phenylalanine 5 5.00 ( 5) 4.87 ( 5) 
Histidine 3 2.82 ( 3) 2.87 ( 3) 
Lysine 11 10.9 (11) 9.9 (10) 
Tryptophan 2 ND ND 
Arginine 5 5.13 ( 5) 6.08 ( 6) 
Relative molar quantities are given for each protein and the figures in 
parentheses indicate integral residue numbers. The amino acid composition 
of notexin, as deduced from primary structure [5], is given for comparison. 
ND, not quantitatively determined 
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was carried out under a nitrogen atmosphere with 10 mM NaOH on 
a Methrom autoburette at pH 8.0 and 40°C. Micelles of sonicated egg 
yolk phosphatidylcholine (type IX-E, Sigma) mixed with an equal 
molar concentration of taurodeoxycholate were used as substrate, in 
the presence of 5 mM Ca(NG&. Final concentrations of 
phosphatidylcholine and taurodeoxycholate were equal to 100 mM in 
a 2-ml reaction volume. 
3. RESULTS AND DISCUSSION 
Chromatography by RP-HPLC on a Nucleosil butyl 
large pore column of the Bio-rex 70 fraction containing 
notexin [6] revealed the presence of several components 
(fig.1). The two main components were designated as 
notechis Np and notechis N,. 
3.1. Functional characterization of notechis NP and 
notechis NS 
Notechis N, and notechis N, behaved similarly in 
three different types of biological assays, suggesting 
that notechis N,, and notechis Ns were exceedingly 
similar proteins. First, they have indistin~ishable in 
vitro esterase properties, when measured in a pH-stat 
apparatus on micelles of phosphatidylcholine mixed 
with taurodeoxycholate (l/l mol/mol). Thus, using 
seven identical concentrations varying between 0 and 
16.5 nM, the apparent maximal velocities to hydrolyze 
100 mM varied identically between 60 and 3 10 + 10 
FM NaOH/min, for both notechis NP and notechis N,. 
Secondly, the two proteins possessed the same in vivo 
toxicity, with a LDx, value of 0.34 -+ 0.02 pg per 
20 I: 2 g female BALBlc mouse, which was also equal 
to the LD~o previously reported for notexin 161. Third- 
ly, both toxins had very similar effects on 
neuromusc~ar transmission. They produced superim- 
posable time-courses of twitch blockade of the biventer 
cervicis preparation in response to nerve stimulation 
(fig.2A). In frog cutaneous pectoris nerve muscle 
preparations, they both produced an initial increase in 
the evoked release of acetylcholine followed by a 
blockade of release (fig.2B). They did not change the 
amplitude or time-course of MEPPS or affect the 
resting membrane potential; i.e. both proteins produc- 
ed a prejunctional block of acetylcholine release. In 
mouse triangul~is sterni preparations, both toxins (220 
nM) produced similar selective reductions in the late 
phase of the perineural waveform, which is associated 
with potassium currents in nerve terminals (data not 
shown). Such an effect was previously noted for the 
mixture of notexin isoforms, ,&bungarotoxin and other 
phospholipase AZ presynaptic toxins [ 131. 
3.2. Biochemical characterization f notechis NP and 
notechis NS 
The amino acid composition of notechis N, (table 1) 
showed no difference with that of notexin 163. In addi- 
tion, we previously showed [lo] that enzymatic treat- 
ment of notechis N, with VS-protease from ~taphy- 
lococcus aureus led to a set of peptides which corres- 
pond to those expected for notexin whose primary 
structure is known [5]. Notechis NP and notexin are 
therefore identical compounds. The amino acid com- 
positions of notechis Ns and notexin were similar 
although not identical: notechis N, has 10 lysine and 6 
arginine residues instead of 11 lysine and 5 arginine 
residues in notexin. Twenty cycle runs from the 
NH2-te~inus revealed a difference at position 16 (table 
2) where lysine in notechis N, (i.e. notexin) was replac- 
ed by an arginine residue in notechis N,. Enzymatic 
digestion of the S-carboxymethylated notechis N, using 
V&protease from S. aureus led to a set of peptides 
which were fractionated as described [lo] and which en- 
compassed the whole protein chain (table 2). 
Automated Edman degradation of these peptides 
revealed no other amino acid modification when com- 
pared to notexin [5]. We concluded that notechis N, 
constitutes an isoform that differs from notexin by a 
single amino acid (Lys+Arg) at position 16. 
Since lysine and arginine are both basic residues, the 
isoelectric point of notechis N, does not differ 
significantly from that of notechis Np. This explains 
why notechis N, was not initially separated by ion- 
exchange chromatography [6]. As shown in the present 
paper this, however, can be achieved using RP-HPLC. 
Since then, notechis N, has been isolated from N. s. 
scutatus venom samples collected in different regions of 
Australia. Depending on the geographic origin of the 
snakes, the relative quantity of notechis N, varied bet- 
ween 38% and 6ltrlo of notexin [15], Interestingly, the 
existence of notechis N, may be related to the mutation 
of a single base in the gene (AAA+AGA or 
AAG--+AGG for Lys+Arg). By contrast with the other 
isoforms notechis II-5 and notechis II-l, no&his N, is 
a single amino acid variant of notexin which further- 
more possesses the same biological activities as notexin. 
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